Cellectar Biosciences CLRB
NASDAQ CLRB
$1.82 -0.01 (-0.55%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cellectar Biosciences (CLRB) Share-based Compensation (2010 - 2025)

Updated

Cellectar Biosciences (CLRB) posted Share-based Compensation of $567,788 for Q4 2025, down 61.8% from $1.49 million a year earlier and unchanged from the prior quarter.

Analysis

Cellectar Biosciences (CLRB) Share-based Compensation (2010 - 2025) Analysis & Trends

For FY2025, Cellectar Biosciences' Share-based Compensation came in at $2.26 million, down 47.0% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 37.1% (FY2020 to FY2025).
  • In prior years, Cellectar Biosciences' Share-based Compensation was $4.27 million in FY2024 (+77.3%), $2.41 million in FY2023 (+65.9%), $1.45 million in FY2022 (+29.2%) and $1.12 million in FY2021 (+140.4%).
  • Quarterly Share-based Compensation has run from a low of $124,564 in Q1 2021 to a high of $1.53 million in Q3 2024 over five years.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with growth averaging 27.1% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 262.2%; the weakest was Q3 2025, with a decline of 63.0%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $567,788 (Q3 2025), $565,391 (Q2 2025) and $562,737 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Cellectar Biosciences 22.38 Mn 22.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 567,788.00
Sep 30, 2025 567,788.00
Jun 30, 2025 565,391.00
Mar 31, 2025 562,737.00
Dec 31, 2024 1.49 Mn
Sep 30, 2024 1.53 Mn
Jun 30, 2024 799,250.00
Mar 31, 2024 454,363.00
Dec 31, 2023 1.08 Mn
Sep 30, 2023 497,878.00
Jun 30, 2023 419,757.00
Mar 31, 2023 408,206.00
Dec 31, 2022 361,447.00
Sep 30, 2022 367,759.00
Jun 30, 2022 419,953.00
Mar 31, 2022 303,805.00
Dec 31, 2021 377,848.00
Sep 30, 2021 421,161.00
Jun 30, 2021 200,617.00
Mar 31, 2021 124,564.00
API Access

Cellectar Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLRB&period=max&api_key=YOUR_API_KEY